Skip to main content
Guttmacher Institute

Search

  • X
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact

Highlights

  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • US policy resources
  • State policy resources
  • International Perspectives on Sexual and Reproductive Health (1975–2020)
  • Perspectives on Sexual and Reproductive Health (1969–2020)

Reports

  • Global
  • United States

Articles

  • Global research
  • US research
  • Policy analysis
  • Guttmacher Policy Review
  • Opinion

Fact Sheets

  • Global
  • United States
  • US State Laws and Policies

Tools

  • Interactive Map: US Abortion Policies and Access After Roe
  • Family Planning Investment Impact Calculator
  • Monthly Abortion Provision Study Dashboard
  • State legislation tracker
  • Public-use data sets

Global

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

US

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

Our Work by Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • Newsletter
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Ways to Give
  • Guttmacher Guardians
  • Guttmacher Legacy Circle
  • Financials
  • Impact Report 2025

Awards & Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship
Donate
Guttmacher Institute
Donate

Highlights

  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • US policy resources
  • State policy resources
  • International Perspectives on Sexual and Reproductive Health (1975–2020)
  • Perspectives on Sexual and Reproductive Health (1969–2020)

Reports

  • Global
  • United States

Articles

  • Global research
  • US research
  • Policy analysis
  • Guttmacher Policy Review
  • Opinion

Fact Sheets

  • Global
  • United States
  • US State Laws and Policies

Tools

  • Interactive Map: US Abortion Policies and Access After Roe
  • Family Planning Investment Impact Calculator
  • Monthly Abortion Provision Study Dashboard
  • State legislation tracker
  • Public-use data sets

Global

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

US

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

Our Work by Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • Newsletter
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Ways to Give
  • Guttmacher Guardians
  • Guttmacher Legacy Circle
  • Financials
  • Impact Report 2025

Awards & Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship
Donate
  • X
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact
BJOG: An International Journal of Obstetrics & Gynaecology

Quality of medication abortion services from pharmacies and drugstores in Ethiopia: A two-stage study

Violet and navy map of Africa with Ethiopia highlighted in orange

Authors

Tesfaye Tufa, University of Toronto Stephanie Küng, Guttmacher Institute Delayehu Bekele, St. Paul Institute for Reproductive Health and Rights, Addis Ababa, Ethiopia Niguse Tadele, Addis Ababa University Mahari Yihdego, Performance Monitoring for Action Ethiopia Kidist Lemma, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia Alice F. Cartwright, Guttmacher Institute

Objective: To assess the quality of medication abortion (MA) services provided in pharmacies and drugstores (‘pharmaceuticaloutlets’) in Ethiopia.

Design: A two-stage cross-sectional study.

Setting: Pharmaceutical outlets in Addis Ababa, Ethiopia.

Sample: Phase 1: 1696 pharmaceutical outlets listed in the Ethiopian Federal Ministry of Health Master Facility Registry, plus 187 additional outlets identified in the field. Phase 2: Selected 600 pharmaceutical outlets.

Methods: After assessing stock availability in phase 1, during phase 2, mystery clients (MCs) visited pharmaceutical outlets to evaluate service quality using an adapted version of the Abortion Care Quality (ACQ) Tool. Descriptive statistics were used to characterise the quality of services provided by the outlets.

Main Outcome Measures: The quality of abortion services provided by pharmaceutical outlets.

Results: Abortion medications were sold without prescriptions in 23.5% of MC visits. Among these sales, client respect (95.7%) and confidentiality (84.4%) were high. Additionally, 67.1% of staff gave correct instructions on dosage, timing, and administration of the medications. However, less than half of the MCs received adequate information on possible complications (36.4%). Almost all medications purchased were unexpired, packaged in aluminum, and of a known brand (96.5%); however, none were characterised as affordable.

Conclusions: Pharmaceutical outlets demonstrated moderate quality for MA services, yet there were notable gaps in counselling for physical side effects and complications, and affordability challenges. With appropriate policy adjustments and training interventions, there is potential to integrate pharmaceutical outlets into the abortion care service delivery infrastructure, ensuring equitable access to safe and effective abortion services in Ethiopia.

Read the full study.

First published on BJOG: An International Journal of Obstetrics & Gynaecology: December 15, 2025

DOI: https://doi.org/10.1111/1471-0528.70110
Source / Available for Purchase
DOI:

Share

Topic

Global

  • Abortion

Geography

  • Global
  • Africa: Ethiopia
Guttmacher Institute

Center facts. Shape policy.
Advance sexual and reproductive rights.®

Donate Now
Newsletter Signup  Contact Us 
  • X
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact

Footer

  • Privacy Policy
  • Accessibility Statement
© 2025 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.